Tlr2 regulates complement-mediated inflammation induced by blood loss during hemorrhage

Shock

Volumn 45, Issue 1, 2016, Pages 33-39

  Goering, Jeremy ^a   Pope, Michael R ^a   Fleming, Sherry D ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

Complement; cytokines; immunohistochemistry; intestine; tissue injury

Indexed keywords

ICOSANOID; INTERLEUKIN 12; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; COMPLEMENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLEEDING; BLOOD VOLUME; C57BL 6 MOUSE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENTERITIS; INFLAMMATION; INFLAMMATORY INFILTRATE; INTESTINE INJURY; MALE; MOUSE; NONHUMAN; WILD TYPE; ANIMAL; BLOOD FLOW; C57BL MOUSE; COMPLICATION; DEFICIENCY; HEMORRHAGIC SHOCK; IMMUNOLOGY; INTESTINE; KNOCKOUT MOUSE; PATHOLOGY; VASCULARIZATION;

ANIMALS; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; INFLAMMATION; INFLAMMATION MEDIATORS; INTESTINES; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; REGIONAL BLOOD FLOW; SHOCK, HEMORRHAGIC; TOLL-LIKE RECEPTOR 2;

EID: 84952342721     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000477     Document Type: Article

References (41)

1. McGuill MW, Rowan AN: Biological effects of blood loss: implications for sampling volumes and techniques. ILAR J 31(4):5-20, 1989.
2. Kristensen AT, Feldman BF: General principles of small animal blood component administration. The Veterinary clinics of North America. Small Animal Pract 25(6):1277-1290, 1995.
3. Fruchterman TM, Spain DA, Wilson MA, Harris PD, Garrison RN: Complement inhibition prevents gut ischemia and endothelial cell dysfunction after hemorrhage/resuscitation. Surgery 124(4):782-792, 1998.
4. Kvarstein G, Mirtheri P, Tonnessen TI: Detection of organ ischemia during hemorrhagic shock. Acta Anaesthesiol Scand 47:675-686, 2003.
5. Shea-Donohue T, Anderson J, Swiecki C: Ischemia/Reperfusion Injury. In GC Tsokos and JL Atkins (eds). Totowa, NJ: Humana Press, 219-248, 2003.
6. Hierholzer C, Kalff JC, Billiar TR, Bauer AJ, Tweardy DJ, Harbrecht BG: Induced nitric oxide promotes intestinal inflammation following hemorrhagic shock. Am J Physiol 286(2):G225-G233, 2004.
7. Szebeni J, Baranyi L, Savay S, Gotze O, Alving CR, Bunger R, Mongan PD: Complement activation during hemorrhagic shock and resuscitation in swine. Shock 20(4):347-355, 2003.
8. Hylton DJ, Hoffman SM, Rooijen NV, Tomlinson S, Fleming SD: Macrophage produced IL-12p70 mediates hemorrhage-induced damage in a complement dependent manner. Shock 35(2):134-140, 2011.
9. Dalle Lucca JJ, Li Y, Simovic M, Pusateri AE, Falabella M, Dubick MA, Tsokos GC: Effects of C1 inhibitor on tissue damage in a porcine model of controlled hemorrhage. Shock 38(1):82-91, 2012.
10. Frink M, Hsieh YC, Thobe BM, Choudhry MA, Schwacha MG, Bland KI, Chaudry IH: TLR4 regulates Kupffer cell chemokine production, systemic inflammation and lung neutrophil infiltration following trauma-hemorrhage. Mol Immunol 44(10):2625-2630, 2007.
11. Fan J: TLR Cross-Talk Mechanism of Hemorrhagic Shock-Primed Pulmonary Neutrophil Infiltration. Open Crit Care Med J 2:1-8, 2010.
12. Fan J, Li Y, Vodovotz Y, Billiar TR, Wilson MA: Hemorrhagic shock-Activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macrophages: role in hemorrhage-primed lung inflammation. Am J Physiol 290(4):L738-L746, 2006.
13. Thobe BM, Frink M, Hildebrand F, Schwacha MG, Hubbard WJ, Choudhry MA, Chaudry IH: The role of MAPK in Kupffer cell toll-like receptor (TLR) 2-, TLR4-, and TLR9-mediated signaling following trauma-hemorrhage. J Cellular Physiol 210(3):667-675, 2007.
14. Barsness KA, Arcaroli J, Harken AH, Abraham E, Banerjee A, Reznikov L, McIntyre RC: Hemorrhage-induced acute lung injury is TLR-4 dependent. Am J Physiol 287(3):R592-R599, 2004.
15. Gill R, Ruan X, Menzel CL, Namkoong S, Loughran P, Hackam DJ, Billiar TR: Systemic inflammation and liver injury following hemorrhagic shock and peripheral tissue trauma involve functional TLR9 signaling on bone marrowderived cells and parenchymal cells. Shock 35(2):164-170, 2011.
16. Li Y, Xiang M, Yuan Y, Xiao G, Zhang J, Jiang Y, Vodovotz Y, Billiar TR, Wilson MA, Fan J: Hemorrhagic shock augments lung endothelial cell activation: role of temporal alterations of TLR4 and TLR2. Am J Physiol Regul Integr Comp Physiol 297(6):R1670-R1680, 2009.
17. HorwoodNJ, PageTH, McDaid JP, PalmerCD, Campbell J, MahonT, BrennanFM, WebsterD, FoxwellBM: Brutons tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production. J Immunol 176(6):3635-3641, 2006.
18. ChangYL, ChenTH, WuYH, ChenGA, WengTH, TsengPH, HsiehSL, FuSL, Lin CH, Chen CJ, et al.: A novel TLR2-Triggered signalling crosstalk synergistically intensifies TNF-mediated IL-6 induction.JCellMolMed 18(7):1344-1357, 2014.
19. Wang M, Krauss JL, Domon H, Hosur KB, Liang S, Magotti P, Triantafilou M, Triantafilou K, Lambris JD, Hajishengallis G: Microbial hijacking of complement-Toll-like receptor crosstalk. Sci Signal 3(109):ra11, 2010.
20. Fleming SD, Tsokos GC: Complement Inhibitors in Rheumatic Diseases. In GC Tsokos (ed). Totowa, NJ: Humana Press, 2000, 443-452.
21. Fleming SD, Phillips LM, Lambris JD, Tsokos GC: Complement component C5a mediates hemorrhage-induced intestinal damage. J Surg Res 150(2):196-203, 2008.
22. Younger JG, Sasaki N, Waite MD, Murray HN, Saleh EF, Ravage ZA, Hirschl RB, Ward PA, Till GO: Detrimental effects of complement activation in hemorrhagic shock. J Appl Physiol 90:441-446, 2001.
23. Spain DA, Fruchterman TM, Matheson PJ, Wilson MA, Martin AW, Garrison RN: Complement activation mediates intestinal injury after resuscitation from hemorrhagic shock. J Trauma 46:224-233, 1999.
24. Pope MR, Fleming SD: TLR2 modulates antibodies required for intestinal ischemia/reperfusion-induced damage and inflammation. J Immunol 194(3):1190-1198, 2015.
25. Chiu C-J, McArdle AH, Brown R, Scott HJ, Gurd FN: Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 101(4):478-483, 1970.
26. Sjogren RW, Colleton C, Shea-Donohue TS: Intestinal myoelectric response in two different models of acute enteric inflammation. Am J Physiol 267:G329-G337, 1994.
27. Zhao A, Urban JF Jr, Anthony RM, Sun R, Stiltz J, Rooijen NV, Wynn TA, Gause WC, Shea-Donohue T: Th2 cytokine-induced alterations in intestinal smooth muscle function depend on alternatively activated macrophages. Gastroenterology 135(1):217-225, 2008.
28. Morris KM, Goldberger G, Colten HR, Aden DP, Knowles BB: Biosynthesis and processing of a human precursor complement protein, pro-C3, in a hepatomaderived cell line. Science 215(4531):399-400, 1982.
29. Pope MR, Hoffman SM, Tomlinson S, Fleming SD: Complement regulates TLR4-mediated inflammatory responses during intestinal ischemia reperfusion. Mol Immunol 48(1-3):356-364, 2010.
30. Pfeifer R, Lichte P, Schreiber H, Sellei RM, Dienstknecht T, Sadeghi C, Pape HC, Kobbe P: Models of hemorrhagic shock: differences in the physiological and inflammatory response. Cytokine 61(2):585-590, 2013.
31. Szabo A, Vollmar B, Boros M, Menger MD: Gender differences in ischemiareperfusion-induced microcirculatory and epithelial dysfunctions in the small intestine. Life Sci 78(26):3058-3065, 2006.
32. Yoshiya K, Lapchak PH, Thai TH, Kannan L, Rani P, Dalle Lucca JJ, Tsokos GC: Depletion of gut commensal bacteria attenuates intestinal ischemia/reperfusion injury. Am J Physiol Gastrointest Liver Physiol 301(6):G1020-G1030, 2011.
33. Zhang CY, Bai N, Zhang ZH, Liang N, Dong L, Xiang R, Liu CH: TLR2 signaling subpathways regulate TLR9 signaling for the effective induction of IL-12 upon stimulation by heat-killed Brucella abortus. Cell Mol Immunol 9(4):324-333, 2012.
34. Watanabe T, Tanigawa T, Kobata A, Takeda S, Nadatani Y, Otani K, Yamagami H, Shiba M, Tominaga K, Fujiwara Y, et al.: Toll-like receptor 2 mediates ischemia-reperfusion injury of the small intestine in adult mice. PLoS One 9(10):e110441, 2014.
35. Sillesen M, Rasmussen LS, Jin G, Jepsen CH, Imam A, Hwabejire JO, Halaweish I, DeMoya M, Velmahos G, Johansson PI, et al.: Assessment of coagulopathy, endothelial injury, and inflammation after traumatic brain injury and hemorrhage in a porcine model. J Trauma Acute Care Surg 76(1):12-19, 2014.
36. Farrar CA, Keogh B, McCormack W, OShaughnessy A, Parker A, Reilly M, Sacks SH: Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia-reperfusion injury. FASEB J 26(2):799-807, 2012.
37. Favre J, Musette P, Douin-Echinard V, Laude K, Henry JP, Arnal JF, Thuillez C, Richard V: Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction. Arterioscler Thromb Vasc Biol 27(5):1064-1071, 2007.
38. Arslan F, Smeets MB, ONeill LA, Keogh B, McGuirk P, Timmers L, Tersteeg C, Hoefer IE, Doevendans PA, Pasterkamp G, et al.: Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-Toll-like receptor-2 antibody. Circulation 121(1):80-90, 2010.
39. Lei C, Wu B, Cao T, Zhang S, LiuM: Activation of the high-mobility group box 1 protein-receptor for advanced glycation end-products signaling pathway in rats during neurogenesis after intracerebral hemorrhage. Stroke 46(2):500-506, 2015.
40. Zou L, Attuwaybi B, Kone BC: Effects of NF-kappa B inhibition on mesenteric ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 284(4):G713-G721, 2003.
41. Zhang X, Kimura Y, Fang C, Zhou L, Sfyroera G, Lambris JD, Wetsel RA, Miwa T, Song WC: Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 110(1):228-236, 2007.